Lung cancer deaths cut in half with AstraZeneca pill, large trial finds

A once-daily pill from drugmaker AstraZeneca cut deaths in half among a subset of early-stage lung cancer patients who had undergone surgery, according to new clinical trial results.The findings were presented Sunday at the American Society of Clinical On